跳至主要内容
临床试验/NCT01162941
NCT01162941Unknown2 期

Efficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP)

Cooperative Study Group A for Hematology2 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2010年2月1日最近更新:
适应症

试验速览

阶段
2 期
发起方
入组人数
38
试验地点
2
主要终点
Proportion who would avoid splenectomy at 6 months of follow up

研究概览

简要总结

Proportion who would avoid splenectomy at 6 months of follow up

详细描述

  1. If urea breath test (+); omeprazole 20mg bid, amoxicillin 1000mg bid and clarithromycin 500mg bid for 1 week.

Second line Helicobacter pylori eradication will be permitted after failure of first line treatment. 2. Anti-D Anti-Ro 50 μg/kg IV for 2 days (D1, 2) 3. Danazol maintenance (from D1): Danazol will be continued at least 3 months. The dose of danazol can be reduced according to the adverse effects, especially in premenopausal women.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 1.ITP is defined by
  • (a) a true thrombocytopenia on blood smear, (b) adequate megakaryopoiesis on bone marrow examination, (c) the absence of clinically apparent associated conditions or cause of thrombocytopenia
  • 2.Steroid dependant ITP: more than 10 mg of prednisolone per day is required to maintain a platelet count above 20X109/L (minimum follow up duration: 3 months after diagnosis)
  • 3.Steroid refractory ITP: a platelet count less than 20X109/L despite of treatment with full dose of steroid (prednisolone 1mg/kg for at least 4 weeks)
  • 4.18 years old or more

排除标准

  • 1.Patients who have a cause of thrombocytopenia such as HIV infection, lymphoproliferative disease, liver disease, definite SLE or drug
  • 2.Pregnancy
  • 3.Splectomized patients
  • 4.Rh- blood type
  • 5.Hemoglobin < 10g/dL
  • 6.Known hypersensitivity to immunoglobulins
  • 7.A positive direct antiglobulin test
  • 8.Clinically relevant hepatic or renal disease

结局指标

主要结局

Proportion who would avoid splenectomy at 6 months of follow up

时间窗: 2years

Proportion who would avoid splenectomy at 6 months of follow up

次要结局

  • SR,IR(2years)

研究者

发起方
Cooperative Study Group A for Hematology
申办方类型
Network

研究点 (2)

Loading locations...

相似试验